L

Laurion Capital Management LP

68 employees

Laurion Capital Management is a private hedge fund sponsor

Investor insights

Sectors invested in

Biotechnology11
Therapeutics6
Software5
Pharmaceutical4
Artificial Intelligence4
Machine Learning4
Health Care4
Life Science3
Pharmaceuticals3
FinTech3
Financial Services3
Genetics2
Drug Repurposing2
Phenomics2
Immuno-oncology2
Drug Discovery2
Diseases of Aging2
Inflammation2
Rare Diseases2
artificial intelligence2

Funding rounds participated in

$105M sweet spot round size

Most of their 18 investments are in rounds between $25M and $150M

Investor type

Hedge Fund

Basic info

Industry

financial services

Date founded

2005

Investments made

C

COMPASS Pathways raised $125M on August 16, 2023

Investors: Vivo Capital, Soleus Capital Management, L.P., Partner Fund Management, RA Capital Management, L.P., Surveyor Capital, Logos Global Management, LP, TCG X, Armistice Capital LLC and Laurion Capital Management LP

A

Axoni raised $20M on April 26, 2023

Investors: Intel Capital, Y Combinator, Nyca Partners and Laurion Capital Management LP

O

Opensee raised $12M on December 15, 2022

Investors: Societe Generale, Omnes and Laurion Capital Management LP

R

Recursion Pharmaceuticals raised $150M on October 25, 2022

Investors: Baillie Gifford, The Invus Group and Laurion Capital Management LP

U

Undisclosed raised $75M on September 30, 2022

Investors: Perceptive Advisors, RA Capital Management, L.P., The Invus Group, Pura Vida Investments, CaaS Capital Management and Laurion Capital Management LP

R

RayzeBio raised $160M on September 13, 2022

Investors: Sands Capital Management, Viking Global Investors, Sofinnova Ventures, Russia technology fund, Soleus Capital Management, L.P., Wellington Management and Laurion Capital Management LP

M

MerQube raised $8M on August 3, 2022

Investors: J.P. Morgan and Laurion Capital Management LP

S

Scipher Medicine raised $110M on February 24, 2022

Investors: ECHO, Hitachi Ventures, Optum Ventures, aMoon Fund, Khosla Ventures, Northpond Ventures, Monashee Investment Management LLC and Laurion Capital Management LP

S

Synthego Corporation raised $200M on February 17, 2022

Investors: Declaration Partners LP, SoftBank Investment Advisers, Gigafund, Wellington Management, RA Capital Management, L.P., Perceptive Advisors, Logos Global Management, LP and Laurion Capital Management LP

A

Ambys Medicines raised $47M on December 21, 2021

Investors: Schroders Capital, Smilegate Investment, Third Rock Ventures and Laurion Capital Management LP

FAQ